ClinicalTrials.gg
RecruitingNCT07557459Updated Oct 13, 2026

Access to Probing and Peri-implant Diseases

An observational study in Peri-implantitis and Peri-implant Bone Loss, sponsored by Arrow Development. Recruiting at 9 sites in Spain. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Arrow Development · Observational

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Oct 13, 2026Now RecruitingFirst site in Spain+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
281
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 50 studies in Peri-Implantitis with a site in Spain — 16 open to participants now, 19 under way, none of them phase 3. Peri-Implantitis · Spain.

Planned enrollment
Largest of 22
281 · median 117
Started
2026
with 5 others
Observational
22 of 50
9 open now
Primary completion
2027-05
later than 13 of 18 live
Registered
44th of 50
by date
Lead sponsor
1 of 50
Arrow Development

Among the 50 studies in Peri-Implantitis with a site in Spain, this one has the largest planned enrollment of the 22 observational ones that give a count, is one of 6 that started in 2026, is one of 22 observational ones, reaches primary completion later than 13 of the 18 other live ones, and was the 44th registered.

Peri-Implantitis

324 studies on the registry are indexed under Peri-Implantitis; 89 are open to participants now.

Browse Peri-Implantitis studies →

Open to participants now

16 of the 50 studies in Peri-Implantitis with a site in Spain are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 50 Peri-Implantitis studies recruiting now, 28 (56%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Peri-Implantitis with a site in Spain, or all of them as a file.
02

Study summary

This multicenter cross-sectional study aims to evaluate the association between access to peri-implant probing and radiographic peri-implant bone loss. Although probing is the primary diagnostic tool for peri-implant diseases, prosthetic design may limit access, potentially affecting diagnosis and disease progression. The study will include patients with dental implants in function for at least three years and will assess clinical, radiographic, and prosthetic variables.

Read the detailed description

Peri-implantitis is a plaque-induced inflammatory condition characterized by inflammation of peri-implant tissues and progressive bone loss. Probing is essential for diagnosis; however, prosthetic design may hinder or prevent proper probing access, potentially compromising diagnostic accuracy.

Despite its clinical relevance, no studies have directly evaluated whether limited access to probing is associated with peri-implant bone loss. This study aims to address this gap.

This is a multicenter cross-sectional observational study conducted in nine private clinics in Spain. A total of 281 patients will be included. Clinical and radiographic data will be collected, including probing accessibility, probing depth, plaque index, bleeding on probing, suppuration, prosthetic design, hygiene accessibility, and radiographic bone levels.

Statistical analysis will evaluate associations between probing access and peri-implant bone loss at both patient and implant levels.

03

Conditions studied

  • Peri-implantitis
  • Peri-implant Bone Loss

Keywords

  • Peri-implantitis
  • Dental Implants
  • Probing
  • Bone Loss
  • Prosthetic Design
  • Oral Hygiene
  • Cross-sectional Study
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients attending participating clinics for the first time for maintenance, review, or treatment, with dental implants in function for at least three years

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years
  • Dental implants loaded for at least 3 years
  • Implant-supported restorations (single, partial fixed, or full-arch)
  • First visit to the clinic (maintenance, review, or treatment)
  • Signed
  • Availability of clinical and radiographic records

Exclusion criteria

Exclusion Criteria:

  • Exposure of the intraosseous portion of the implant
  • Evident prosthetic misfit
  • Inability to provide
  • Lack of cooperation for clinical examination
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
281 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testPeri-implant probing

    This is a non-interventional, observational cross-sectional multicenter study. No therapeutic, surgical, or pharmacological interventions are performed as part of the study. All procedures correspond to standard clinical practice and include: Peri-implant clinical examination, consisting of probing depth measurements at six sites per implant using a manual periodontal probe. When access is limited, a flexible plastic probe may be used. Assessment of probing accessibility, categorized according to the angulation and feasibility of probe insertion without prosthesis removal (possible, limited, or impossible). Recording of routine clinical parameters, including plaque presence, bleeding on probing, suppuration, and patient-reported hygiene practices. Radiographic assessment, consisting of standardized periapical radiographs obtained using a parallel technique for the evaluation of marginal bone levels. No modifications to the patients' treatment, prosthetic design, or maintenance protocol

06

What researchers measure

Primary outcomes

  1. Association between probing access and peri-implant radiographic bone loss

    Evaluation of whether limited or impossible probing access is associated with increased radiographic bone loss (measured in mm from implant platform to bone level).

    Time frame: Baseline (cross-sectional assessment)

Secondary outcomes

  1. Prevalence of implants with limited or no probing accessibility

    Proportion of implants classified as having limited or impossible access to peri-implant probing, based on probe angulation and feasibility without prosthesis removal.

    Time frame: Assessed at the baseline visit (single cross-sectional evaluation)

  2. Prevalence of non-hygienizable implant-supported prostheses

    Proportion of implant-supported restorations classified as non-hygienizable, defined as the inability to pass an interdental brush of at least 0.4 mm diameter

    Time frame: Assessed at the baseline visit (single cross-sectional evaluation)

  3. Association between hygiene accessibility and peri-implant bone loss

    Evaluation of the relationship between prosthetic hygiene accessibility (hygienizable vs non-hygienizable) and radiographic peri-implant marginal bone levels.

    Time frame: Assessed at the baseline visit (single cross-sectional evaluation)

  4. Clinical peri-implant parameters

    Assessment of peri-implant clinical parameters, including plaque presence, bleeding on probing, suppuration, and probing depth (when measurable), in relation to probing accessibility.

    Time frame: Assessed at the baseline visit (single cross-sectional evaluation)

  5. Patient-related and implant-related factors associated with probing accessibility

    Exploratory analysis of the association between probing accessibility and variables such as type of prosthesis (single, partial, full-arch), implant characteristics (bone level/tissue level, connection type), and patient-related factors (oral hygiene habits, maintenance frequency, history of periodontitis).

    Time frame: Assessed at the baseline visit (single cross-sectional evaluation)

07

Study locations

9 of 9 sites recruiting
  • Clínica Barbieri
    A Coruña, A Coruña 15004, Spain
    Recruiting
  • PerioCentrum Guadalajara
    Guadalajara, Guadalajara 10991, Spain
    Recruiting
  • Clínica Bio
    Madrid, Madrid 28001, Spain
    Recruiting
  • Centro de Periodoncia e Implantes Aranda-Macera
    Madrid, Madrid 28007, Spain
    Recruiting
  • Madrid Perio & Implant Clinic
    Madrid, Madrid 28007, Spain
    Recruiting
  • Salud y Estética Dental SCH Zurbano S.L.
    Madrid, Madrid 28010, Spain
    Recruiting
  • Clínica Sánchez Cortés
    Pozuelo de Alarcón, Madrid 28224, Spain
    Recruiting
  • Clínica Dental NEXUS
    Málaga, Málaga 29008, Spain
    Recruiting
  • Clínica Ortiz-Vigón
    Bilbao, Vizcaya 48008, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Sep 2026 (actual). Primary completion is estimated for May 2027, 8 months after the start.

Start moved once since we started tracking on Sep 25, 2026: May 2026 → Sep 2026, on Oct 13, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 23, 2026
First posted
Apr 29, 2026
StartActual
Sep 1, 2026was May 2026
Primary completionEst.
May 2027
CompletionEst.
Dec 2027
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 13, 2026
Sites
9 sites added — first site in Spain
Show 9 added (9 Spain)
  • Clínica Barbieri · A Coruña, Spain
  • PerioCentrum Guadalajara · Guadalajara, Spain
  • Clínica Bio · Madrid, Spain
  • Centro de Periodoncia e Implantes Aranda-Macera · Madrid, Spain
  • Madrid Perio & Implant Clinic · Madrid, Spain
  • Salud y Estética Dental SCH Zurbano S.L. · Madrid, Spain
  • Clínica Sánchez Cortés · Pozuelo de Alarcón, Spain
  • Clínica Dental NEXUS · Málaga, Spain
  • Clínica Ortiz-Vigón · Bilbao, Spain
Oct 13, 2026
Start date
May 2026→Sep 1, 2026 (actual)
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Not yet recruiting→Recruiting
    9 sites added — first site in Spain
    Show 9 added (9 Spain)
    • Clínica Barbieri · A Coruña, Spain
    • PerioCentrum Guadalajara · Guadalajara, Spain
    • Clínica Bio · Madrid, Spain
    • Centro de Periodoncia e Implantes Aranda-Macera · Madrid, Spain
    • Madrid Perio & Implant Clinic · Madrid, Spain
    • Salud y Estética Dental SCH Zurbano S.L. · Madrid, Spain
    • Clínica Sánchez Cortés · Pozuelo de Alarcón, Spain
    • Clínica Dental NEXUS · Málaga, Spain
    • Clínica Ortiz-Vigón · Bilbao, Spain
    Start date May 2026→Sep 1, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07557459
Lead sponsor
Arrow Development
Collaborators
Clinica Dental Nexus, Malaga, Salud y Estetica Dental SCH Zurbano S.L, Clinica Bio, Madrid, Centro de Periodoncia e Implantes Aranda-Macera, Madrid, Clínica Sánchez Cortés, Madrid, Madrid Perio & Implant Clinic, Madrid, Clínica Barbieri, A Coruña, Clinica Ortiz-Vigon, Bilbao, PerioCentrum Guadalajara
Responsible party
Alberto Ortiz Vigon (Principal Investigator, Dentist (DDS, PhD, MBA), Arrow Development) — Principal investigator
First posted
Apr 29, 2026
Start date
Sep 1, 2026
Primary completion
May 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Oct 13, 2026

Study contacts

Maite Trobo
Contact
arrow@archealth.eu
+34747426390

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion